Prevalence of nonalcoholic fatty liver disease (NAFLD) and utility of FIBROspect II to detect liver fibrosis in morbidly obese hispano-american patients undergoing gastric bypass

Obesity Surgery

Volumn 20, Issue 12, 2010, Pages 1647-1653

  Guajardo Salinas, Gustavo Eugenio ^b   Hilmy, Ashraf ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b NONE

Author keywords

Gastric bypass; Liver fibrosis; Morbid obesity; NAFLD; NASH

Indexed keywords

ADULT; ARTICLE; CLINICAL EVALUATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FATTY LIVER; FEMALE; HISPANIC; HUMAN; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; NONALCOHOLIC FATTY LIVER; PREDICTION; PREVALENCE; PRIORITY JOURNAL; ROUX Y ANASTOMOSIS; SCORING SYSTEM; SCREENING TEST; SENSITIVITY AND SPECIFICITY; STOMACH BYPASS; ULTRASOUND;

ADULT; BIOLOGICAL MARKERS; BIOPSY; BODY MASS INDEX; COMORBIDITY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FATTY LIVER; FEMALE; GASTRIC BYPASS; HEMATOLOGIC TESTS; HISPANIC AMERICANS; HUMANS; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; OBESITY, MORBID; PREDICTIVE VALUE OF TESTS; PREVALENCE; RETROSPECTIVE STUDIES;

EID: 78651242746     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11695-009-0027-0     Document Type: Article

References (17)

1. KM Flegal MD Carroll CL Ogden, et al. 2002 Prevalence and trends in obesity among US adults, 1999-2000 JAMA 288 1723 1727 10.1001/jama.288.14.1723 12365955
2. CL Ogden MD Carroll LR Curtin, et al. 2006 Prevalence of overweight and obesity in the United States, 1999-2004 JAMA 295 1549 1555 1:CAS:528: DC%2BD28Xjt12itrk%3D 10.1001/jama.295.13.1549 16595758
3. L Residori P Garcia-Lorda L Flancbaum, et al. 2003 Prevalence of co morbidities in obese patients before bariatric surgery: effect of race Obes Surg 12 333 340 10.1381/096089203765887615 (Pubitemid 36718448)
4. Guajardo-Salinas, et al. 2008 Predictors of weight loss and effectiveness of Roux-en-Y gastric bypass in the morbidly obese Hispano-American population Obes Surg 18 11 1369 1375 10.1007/s11695-008-9461-7 18324448
5. DB Allison KR Fontaine JE Manson, et al. 1999 Annual deaths attributable to obesity in the United States JAMA 282 1530 1538 1:STN:280: DC%2BD3c%2Fht1WrsQ%3D%3D 10.1001/jama.282.16.1530 10546692 (Pubitemid 29504046)
6. AM Diehl 2005 Hepatic complications of obesity Gastroenterol Clin North Am 34 45 61 10.1016/j.gtc.2004.12.012 15823438 (Pubitemid 40488731)
7. DN Amarapurkar E Hashimoto LA Lesmana, et al. 2007 How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences? J Gastroenterol Hepatol 22 6 788 793 10.1111/j.1440-1746.2007. 05042.x 17565631 (Pubitemid 46911047)
8. BR Bacon MJ Farahvash CG Janney, et al. 1994 Nonalcoholic steatohepatitis: an expanded clinical entity Gastroenterology 107 4 1103 1:STN:280:DyaK2M%2FhtFansw%3D%3D 7523217
9. PM Gholam L Flancbaum JT Machan, et al. 2007 Nonalcoholic fatty liver disease in severely obese subjects Am J Gastroenterol 102 399 408 1:CAS:528:DC%2BD2sXivF2ksb0%3D 10.1111/j.1572-0241.2006.01041.x 17311652 (Pubitemid 46160554)
10. Mottin, et al. 2005 Histological behavior of hepatic steatosis in morbidly obese patients after weight loss induced by bariatric surgery Obes Surg 15 6 788 793 10.1381/0960892054222830 15978148 (Pubitemid 40904867)
11. AM Almeida HP Cotrim DBV Barbosa, et al. 2008 Fatty liver disease in severe obese patients: diagnostic value of abdominal ultrasound World J Gastroenterol 14 1415 1418 10.3748/wjg.14.1415 (Pubitemid 351425224)
12. P Angulo JM Hui G Marchesini, et al. 2007 The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD Hepatology 45 4 846 854 1:CAS:528:DC%2BD2sXltlWis7k%3D 10.1002/hep.21496 17393509 (Pubitemid 46631552)
13. F Imbert-Bismut V Ratziu L Pieroni, et al. 2001 Biochemical markers of liver fibrosis: a prospective study Lancet 357 1069 1075 1:CAS:528: DC%2BD3MXislGns70%3D 10.1016/S0140-6736(00)04258-6 11297957 (Pubitemid 32322537)
14. C Christensen D Bruden S Livingston, et al. 2006 Diagnostic accuracy of a fibrosis serum panel (FIBROSpect II) compared with Knodell and Ishak liver biopsy scores in chronic hepatitis C patients J Viral Hepatitis 13 10 652 658 1:STN:280:DC%2BD28rks1Cnsw%3D%3D 10.1111/j.1365-2893.2006.00743.x (Pubitemid 44401193)
15. A Bravo S Sheth S Chopra 2001 Liver biopsy N Engl J Med 344 7 495 500 1:STN:280:DC%2BD3M7ksVehtw%3D%3D 10.1056/NEJM200102153440706 11172192 (Pubitemid 32164902)
16. A Zaman H Rosen K Ingram, et al. 2007 Assessment of FIBROspect II to detect hepatic fibrosis in chronic hepatitis C patients Am J Med 120 3 280.e9 280.e14 10.1016/j.amjmed.2006.06.044 (Pubitemid 46341167)
17. K Patel SC Gordon I Jacobson, et al. 2004 Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to advanced liver fibrosis in chronic hepatitis C patients J Hepatol 41 935 942 1:CAS:528:DC%2BD2cXhtVCgsLzK 10.1016/j.jhep.2004.08.008 15582126 (Pubitemid 39575660)